Melissa M. Tomkiel
CIK 1859484 · Co-CEO and General Counsel · last filed 2026-09-25
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
BLDEW price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
31 HUDSON YARDS, 14TH FLOOR
NEW YORK, NY 10001
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SRTA | Co-CEO and General Counsel | 2,244,475 | $4.44 | $9.97M | -$174.5K | 5 | 2026-09-25 |
| Strata Critical Medical, Inc. (SRTAW) Delisted | Co-CEO and General Counsel | 2,244,254 | $0.00 | $1.3K | $0 | 9 | 2026-04-27 |
| Strata Critical Medical, Inc. (BLDEW) Delisted | President and General Counsel | 1,169,334 | $0.18 | $209.8K | -$2.37M | 39 | 2025-08-07 |
Recent Filings · Page 4 of 7
63 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-06-12 | Strata Critical Medical, Inc. (BLDEW) Delisted | Exer (M) | +10,253 | $1.8K | EDGAR |
| 2024-04-17 | Strata Critical Medical, Inc. (BLDEW) Delisted | Sell (S) | −11,734 | -$38.5K | EDGAR |
| 2024-04-05 | Strata Critical Medical, Inc. (BLDEW) Delisted | Sell (S) | −22,836 | -$74.9K | EDGAR |
| 2024-04-04 | SRTA | Notice (144) | −11,734 | -$38.5K | EDGAR |
| 2024-03-20 | Strata Critical Medical, Inc. (BLDEW) Delisted | Exer (M) | +27,857 | $5.0K | EDGAR |
| 2024-03-15 | Strata Critical Medical, Inc. (BLDEW) Delisted | Mixed | +3,730 | -$129.7K | EDGAR |
| 2024-03-13 | SRTA | Notice (144) | −58,464 | -$138.2K | EDGAR |
| 2024-03-12 | Strata Critical Medical, Inc. (BLDEW) Delisted | Grant (A) | +22,836 | $0 | EDGAR |
| 2024-01-03 | Strata Critical Medical, Inc. (BLDEW) Delisted | Exer (M) | +30,148 | $5.4K | EDGAR |
| 2023-12-15 | Strata Critical Medical, Inc. (BLDEW) Delisted | Sell (S) | −35,969 | -$111.8K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.